797 related articles for article (PubMed ID: 8745846)
1. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.
Tirimanna PR; Den Otter JJ; Van Schayck CP; Van Herwaarden CL; Folgering H; Van Weel C
Br J Gen Pract; 1996 Jan; 46(402):15-8. PubMed ID: 8745846
[TBL] [Abstract][Full Text] [Related]
2. Asthma and chronic bronchitis. Can family physicians predict rates of progression?
van Schayck CP; Dompeling E; Putters R; Molema J; van Weel C
Can Fam Physician; 1995 Nov; 41():1868-76. PubMed ID: 8563504
[TBL] [Abstract][Full Text] [Related]
3. Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study.
van Schayck CP; Dompeling E; van Herwaarden CL; Folgering H; Akkermans RP; van den Broek PJ; van Weel C
Br J Gen Pract; 1995 May; 45(394):239-44. PubMed ID: 7619569
[TBL] [Abstract][Full Text] [Related]
4. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
[TBL] [Abstract][Full Text] [Related]
5. [The course of bronchial asthma in adults. Factors of importance for the annual decline of lung function].
Ulrik CS; Backer V; Dirksen A
Ugeskr Laeger; 1993 Mar; 155(12):867-71. PubMed ID: 8480383
[TBL] [Abstract][Full Text] [Related]
6. Rate of decline of lung function in subjects with asthma.
Peat JK; Woolcock AJ; Cullen K
Eur J Respir Dis; 1987 Mar; 70(3):171-9. PubMed ID: 3569449
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of lung function in patients admitted to hospital with acute exacerbation of chronic obstructive pulmonary disease or asthma].
Lange P; Rasmussen L; Said NM; Ravnholt MM
Ugeskr Laeger; 2005 Nov; 167(48):4563-6. PubMed ID: 16324438
[TBL] [Abstract][Full Text] [Related]
8. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
[TBL] [Abstract][Full Text] [Related]
9. FEF75 in asthma management.
Luigi DB; Emanuel DT; Federica DB; Fabrizio DT
Eur Ann Allergy Clin Immunol; 2007 Dec; 39(10):333-6. PubMed ID: 18386434
[TBL] [Abstract][Full Text] [Related]
10. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children.
Strunk RC; Szefler SJ; Phillips BR; Zeiger RS; Chinchilli VM; Larsen G; Hodgdon K; Morgan W; Sorkness CA; Lemanske RF;
J Allergy Clin Immunol; 2003 Nov; 112(5):883-92. PubMed ID: 14610474
[TBL] [Abstract][Full Text] [Related]
11. [Clinical application of portable spirometry in asthma].
Yin XW; Han JN; Zhu YJ; Xu WB; Van de Woestijne KP; Van den Bergh O
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):337-43. PubMed ID: 16038271
[TBL] [Abstract][Full Text] [Related]
12. Adequacy of control of asthma in a general practice. Is maximum peak expiratory flow rate a valid index of asthma severity?
Morris NV; Abramson MJ; Strasser RP
Med J Aust; 1994 Jan; 160(2):68-71. PubMed ID: 8309371
[TBL] [Abstract][Full Text] [Related]
13. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
14. Ventilatory capacity, working capacity and exercise-induced bronchoconstriction in a population sample of subjects with bronchial asthma or chronic bronchitis.
Kiviloog J; Irnell L; Eklund G
Scand J Respir Dis; 1975 Aug; 56(2):73-83. PubMed ID: 1166292
[TBL] [Abstract][Full Text] [Related]
15. [Symptoms, FEV1/FVC, and peak flow as indices of the control of asthma].
Zang M; Nishimura K; Ikeda A; Tsukino M; Koyama H; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):270-4. PubMed ID: 8778465
[TBL] [Abstract][Full Text] [Related]
16. Variability of lung function predicts loss of asthma control following withdrawal of inhaled corticosteroid treatment.
Thamrin C; Taylor DR; Jones SL; Suki B; Frey U
Thorax; 2010 May; 65(5):403-8. PubMed ID: 20435861
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal follow-up of lung function from childhood to adolescence in prematurely born patients with neonatal chronic lung disease.
Koumbourlis AC; Motoyama EK; Mutich RL; Mallory GB; Walczak SA; Fertal K
Pediatr Pulmonol; 1996 Jan; 21(1):28-34. PubMed ID: 8776263
[TBL] [Abstract][Full Text] [Related]
18. Persistence and new onset of asthma and chronic bronchitis evaluated longitudinally in a community population sample of adults.
Postma DS; Lebowitz MD
Arch Intern Med; 1995 Jul; 155(13):1393-9. PubMed ID: 7794088
[TBL] [Abstract][Full Text] [Related]
19. Observational study of the natural history of eosinophilic bronchitis.
Berry MA; Hargadon B; McKenna S; Shaw D; Green RH; Brightling CE; Wardlaw AJ; Pavord ID
Clin Exp Allergy; 2005 May; 35(5):598-601. PubMed ID: 15898981
[TBL] [Abstract][Full Text] [Related]
20. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex.
Dijkstra A; Vonk JM; Jongepier H; Koppelman GH; Schouten JP; ten Hacken NH; Timens W; Postma DS
Thorax; 2006 Feb; 61(2):105-10. PubMed ID: 16308336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
